Generate Biomedicines Inc.
GENB | NASDAQ
$13.40
-$1.06 (-7.33%)
Nov 2, 2026, 3:15 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
PE Ratio | -2.54 | -7.53 |
PEG Ratio | -0.01 | n/a |
PS Ratio | 19.87 | 78.80 |
PB Ratio | -1.03 | -3.71 |
P/FCF Ratio | -3.10 | -13.30 |
P/OCF Ratio | -3.16 | -13.69 |
OCF/S Ratio | -629.04 | -575.54 |
Debt / Equity Ratio | -0.11 | -0.18 |
Quick Ratio | 2.85 | 4.70 |
Current Ratio | 2.85 | 4.70 |
Asset Turnover | 0.10 | 0.04 |
Interest Coverage | -206.92 | -92.98 |
Return on Equity | 32.98% | 39.99% |
Return on Assets | -61.53% | -33.53% |
Return on Invested Capital | -89.38% | -43.93% |
Dividend Yield | n/a | n/a |
Payout Ratio | n/a | n/a |
FCF Payout Ratio | n/a | n/a |
Gross Profit Margin | 100% | 100% |
Net Profit Margin | -636.99% | -849.36% |
Pretax Profit Margin | -698.59% | -885.54% |
Operating Profit Margin | -737.04% | -962.60% |
FCF Margin | -640.06% | -592.39% |
EBITDA Margin | -653.71% | -800.16% |
Add to Watchlist
Select watchlists to add or remove GENB